<DOC>
	<DOCNO>NCT01847131</DOCNO>
	<brief_summary>Background Allergic rhinitis common health problem worldwide prevalence 10-25 % , pose significant impact quality life patient . In Thailand , prevalence allergic rhinitis general population 13.5 % , frequency allergic rhinitis increase 23 % 38 % child , 61.9 % graduate student . Despite intranasal steroid current first-line treatment patient allergic rhinitis , 60 % patient achieve excellent control . Persistent nasal congestion major symptom difficult control patient . Data limit efficacy safety additional use 0.05 % intranasal oxymetazoline hydrochloride ( OXY ) persistent nasal congestion adequately respond recommended dos intranasal steroid ( INS ) oral antihistamine ( OAH ) . Objective To determine efficacy safety additional use OXY persistent nasal congestion allergic rhinitis non-allergic rhinitis patient inadequately control combination treatment INS OAH . Methods The investigator perform 6-week , randomize , double blind , placebo control , clinical trial 50 patient allergic rhinitis non-allergic rhinitis inadequately control combination treatment INS oral antihistamine ( OAH ) . After initial screening , qualified individual randomize 2 group include treatment group control group . The treatment group receive INS ( 2 puff nostril twice daily ) OAH ( 1 tablet daily ) plus OXY ( 2 puff nostril twice daily ) The control group receive INS ( 2 puff nostril twice daily ) OAH ( 1 tablet daily ) plus placebo ( 2 puff nostril twice daily ) .</brief_summary>
	<brief_title>Effectiveness Oxymetazoline Added Nasal Steroid Rhinitis With Persistent Nasal Obstruction</brief_title>
	<detailed_description>All participant continue medication 4 week , stop use interventional medication still take INS ( 2 puff nostril twice daily ) OAH ( 1 tablet daily ) 2 week . Then , participant come last visit see whether rebound nasal symptom occur . Participants ask record nasal symptom diary card , nasal peak inspiratory flow . Rhinoconjunctivitis Quality life Questionnaire ( Rcq ) record visit .</detailed_description>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Nasal Obstruction</mesh_term>
	<mesh_term>Oxymetazoline</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<criteria>Patient 18 year age great Diagnosis allergic nonallergic rhinitis persistent nasal obstruction Being treat intranasal steroid oral antihistamine Underlying disease hypertension Use oral nasal decongestant 7 day prior enter study Nasal polyp significant deviate nasal septum Respiratory tract infection 14 day prior enter study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Rhinitis</keyword>
	<keyword>Oxymetazoline</keyword>
</DOC>